ArticleOncotarget2012

Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels.

Daniela Bressanin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.